Powered by The Dementia Service, the leading UK Private Memory Clinic

Electrocardiogram before treatment

Reading time: 4 minutes Last reviewed: 8th May 2026 Next review: 8th May 2027 Clinically reviewed by The Dementia Service
Electrocardiogram before treatment

In plain English

An Electrocardiogram is a routine part of UK dementia assessment, particularly before starting Cholinesterase Inhibitor medication. The test is quick, painless and provides important safety information.

What an Electrocardiogram is

An Electrocardiogram (ECG) records the electrical activity of the heart over a few seconds. Ten small adhesive electrodes are placed on the chest, arms and legs. The test takes 5 minutes from start to finish. There is no preparation and no aftercare.

Why an ECG is part of dementia assessment

Before Cholinesterase Inhibitor prescribing

Cholinesterase Inhibitors (Donepezil, Galantamine, Rivastigmine) can slow the heart rate slightly. A baseline ECG identifies pre-existing slow heart rate (bradycardia), heart block, or other conduction problems that would make these medicines unsuitable or require cardiology input. The ECG is performed before starting and informs the prescribing decision.

Identifying Atrial Fibrillation

Atrial Fibrillation is common in older adults and is an important risk factor for stroke and Vascular Dementia. The ECG identifies it. Treatment with anticoagulation reduces stroke risk substantially.

Detecting QT prolongation

Some medicines prolong the QT interval, increasing arrhythmia risk. Several medicines used in older adults can affect QT, and an ECG identifies a prolonged baseline that would influence prescribing.

Other findings

Past silent heart attack, left ventricular hypertrophy (suggesting longstanding Hypertension), and various rhythm abnormalities can all show on the ECG.

What the report means

A typical ECG report describes:

Most reports finish with a clinical impression: "normal sinus rhythm" or specific abnormalities highlighted.

When the ECG is abnormal

If you cannot have an ECG

Most people can have an ECG. Where it is genuinely not possible (severe agitation, dressings, pacemaker considerations), a clinical risk assessment may proceed without an ECG, with closer monitoring of pulse and any cardiac symptoms after starting medication.

Holter monitoring

Where intermittent rhythm problems are suspected, a 24-hour, 48-hour or 7-day ambulatory ECG (Holter monitor) may be requested. This is a small wearable device that records continuously and is reviewed by a cardiologist.

Where to have an ECG

NHS ECGs are done at GP practices and in hospital outpatient settings. Private ECGs are widely available through community phlebotomy services and private memory clinics including The Dementia Service.

Frequently asked questions

Does the ECG hurt?

No. The adhesive electrodes feel like sticky pads. The recording itself is passive and takes a few seconds.

Why do I need an ECG before Donepezil?

Donepezil and other Cholinesterase Inhibitors can slow the heart rate slightly. The ECG ensures the baseline heart rate and conduction are safe for the medicine.

What if I have Atrial Fibrillation?

Treatment focuses on stroke prevention (usually with an anticoagulant such as Apixaban) and rate or rhythm control. Atrial Fibrillation is treatable; identifying it on the ECG is a benefit of the test.

Will I need a 24-hour Holter?

Only if intermittent rhythm problems are suspected. Most people have a standard 12-lead ECG and nothing further.

Can I have an ECG privately?

Yes. Private clinics including The Dementia Service can arrange ECGs as part of an assessment package.

What to do next

  1. Confirm your ECG has been done before starting any Cholinesterase Inhibitor.
  2. Discuss any abnormal finding with your GP or cardiologist.
  3. If Atrial Fibrillation is identified, discuss anticoagulation.

References

  1. NICE TA217: Donepezil, Galantamine, Rivastigmine and Memantine for Alzheimer's Disease.
  2. British National Formulary. Cholinesterase inhibitors cardiac monitoring.
  3. NICE NG196: Atrial Fibrillation: diagnosis and management.
  4. British Society for Heart Failure. ECG interpretation.